Suppr超能文献

慢性阻塞性肺疾病新细菌菌株加重的炎症特征

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.

作者信息

Sethi Sanjay, Wrona Catherine, Eschberger Karen, Lobbins Phyllis, Cai Xueya, Murphy Timothy F

机构信息

Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, University at Buffalo, State University of New York, USA.

出版信息

Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7. doi: 10.1164/rccm.200708-1234OC. Epub 2007 Dec 13.

Abstract

RATIONALE

Whether the airway and systemic inflammatory profile in bacterial exacerbations of chronic obstructive pulmonary disease (COPD) is distinct from nonbacterial exacerbations is unclear. Previous studies have not used molecular typing of bacterial pathogens, which is required to accurately define bacterial infection in COPD. The relationship between clinical severity and course of exacerbation and inflammation is also not fully understood.

OBJECTIVES

To determine if (1) systemic and airway inflammation is distinct in new bacterial strain exacerbations and (2) clinical severity and resolution of exacerbations is related to airway and systemic inflammation.

METHODS

In a prospective longitudinal cohort study in COPD, sputum and serum samples obtained before, at, and following exacerbations during a 2-year period were studied.

MEASUREMENTS AND MAIN RESULTS

Clinical information, molecular typing of bacterial pathogens, sputum IL-8, tumor necrosis factor (TNF)-alpha and neutrophil elastase, and serum C-reactive protein. From 46 patients, 177 exacerbations were grouped as new strain, preexisting strain, other pathogen, and pathogen negative. New strain exacerbations were associated with significantly greater increases from baseline in sputum TNF-alpha and neutrophil elastase, and in serum C-reactive protein compared with the other three groups. Increases in inflammatory markers were similar among the other three groups. Clinical resolution was accompanied by resolution of inflammation to preexacerbation levels, whereas persistent symptoms were paralleled by persistently elevated inflammation. Clinical exacerbation severity was significantly correlated with levels of all four markers.

CONCLUSIONS

Neutrophilic airway inflammation and systemic inflammation are more intense with well-defined bacterial exacerbations than with nonbacterial exacerbations. Clinical course of exacerbation and inflammation are closely linked.

摘要

原理

慢性阻塞性肺疾病(COPD)细菌感染加重期的气道和全身炎症特征是否与非细菌感染加重期不同尚不清楚。既往研究未采用细菌病原体的分子分型,而这是准确界定COPD细菌感染所必需的。临床严重程度与加重期病程及炎症之间的关系也尚未完全明确。

目的

确定(1)新细菌菌株加重期的全身和气道炎症是否不同,以及(2)加重期的临床严重程度和缓解是否与气道和全身炎症有关。

方法

在一项针对COPD患者的前瞻性纵向队列研究中,对2年期间加重期之前、期间及之后获取的痰液和血清样本进行研究。

测量指标及主要结果

临床信息、细菌病原体的分子分型、痰液白细胞介素-8、肿瘤坏死因子(TNF)-α和中性粒细胞弹性蛋白酶,以及血清C反应蛋白。46例患者的177次加重期被分为新菌株、原有菌株、其他病原体和病原体阴性组。与其他三组相比,新菌株加重期患者痰液TNF-α、中性粒细胞弹性蛋白酶及血清C反应蛋白较基线水平显著升高。其他三组炎症标志物的升高情况相似。临床缓解伴随着炎症消退至加重前水平,而持续症状则与炎症持续升高并行。临床加重期严重程度与所有四种标志物水平显著相关。

结论

明确的细菌感染加重期的嗜中性气道炎症和全身炎症比非细菌感染加重期更强烈。加重期的临床病程与炎症密切相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验